Skip to content

CEO Spotlight: James West

CEO Spotlight: James West

As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a new Electronic Medical Record system in the medical marijuana industry.

James first became interested in CBD and its benefits after coming across a number of news stories covering the revolutionary medical treatment. To start his journey into the medical marijuana industry, James conducted research on his own and spoke with numerous medical professionals on the topic. While researching, he realized that many medical professionals were interested in prescribing medical cannabis, but lacked access to sufficient research and data.

To help fix this issue, James created Arfinn Med, the first ever clinician-based medical professional and patient efficacy portal for medical marijuana treatment. With his experience top-of-mind, James’ objective for creating the Arfinn Med portal was to provide a digital warehouse of data from credible medical sources.

Arfinn Med is a free service that welcomes any and all licensed medical professionals to register, no matter the state of practice and medical marijuana legalization. Some additional features the portal provides Arfinn Med members include direct patient updates, the ability to view previous case studies conducted by licensed medical professionals, industry updates and so much more!

If you’re ready to join a nationwide network of licensed medical professionals to learn and share best practices and treatment efficacies for medical marijuana, join Arfinn Med for free today.

Stories you may be interested in

Substance in cannabis ‘could boost pancreatic cancer treatments’

A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More

Medical Marijuana a Hit With Seniors

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research

A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More